November 2017
Providence Cancer Institute is currently conducting more than 150 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
Revolutionizing immunotherapy for renal cancer
T-cell checkpoint antibodies have revolutionized immunotherapy for cancer, including renal cancer. At Providence Cancer Institute, several clinical trials of these novel approaches are open now to patients with renal cancer, including these:

From Center to Institute
As our cancer treatment services, clinics and research programs have expanded, Providence Cancer Center has outgrown its name. Today, all of our cancer care and research programs operate together, regionwide, under the name Providence Cancer Institute. It is our honor and privilege to work with you to #FINISHCANCER.
All current open studies:
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.